Related Experiment Video

Updated: Sep 30, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
07:32

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography

Published on: March 30, 2022

Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics

Hideaki Nagase1, Keith Brew

  • 1The Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, London, UK. h.nagase@ic.ac.uk

Arthritis Research
|July 12, 2002
PubMed

Insights

Tissue inhibitors of metalloproteinases (TIMPs) regulate matrix metalloproteinases (MMPs), which are involved in development and disease. This review explores TIMP structures, functions, and therapeutic potential.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pathology

Background:

  • Matrix metalloproteinases (MMPs) are crucial for biological processes like development and wound healing.
  • Dysregulated MMP activity is linked to diseases including cancer metastasis, arthritis, and fibrosis.
  • Tissue inhibitors of metalloproteinases (TIMPs) are key endogenous regulators of MMPs.

Purpose of the Study:

  • To review the structures and inhibition mechanisms of TIMPs.
  • To discuss the biological activities and unique properties of TIMP-3.
  • To explore the therapeutic potential of engineered TIMP variants.

Main Methods:

  • Literature review of TIMP and MMP research.
  • Analysis of TIMP structures and inhibition mechanisms.
  • Discussion of mutagenesis studies altering TIMP specificity.

Main Results:

  • TIMPs effectively control MMP activity through specific binding.
  • TIMP-3 exhibits unique biological roles and properties.
  • Mutagenesis can modify TIMP specificity towards MMPs.

Conclusions:

  • TIMPs are vital regulators of MMPs with significant implications in health and disease.
  • TIMP-3 presents unique therapeutic opportunities.
  • Engineered TIMP variants hold promise for future therapeutic applications.

More Related Videos

In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition09:05

In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition

Published on: August 20, 2016

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization08:13

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization

Published on: December 3, 2020

Related Concept Videos

In-vitro Mutagenesis (Gene Knockouts)02:29

In-vitro Mutagenesis (Gene Knockouts)

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.